We handle the full lifecycle of pharmaceutical market entry and operations across Africa and Asia-Pacific.
Your product works. Your market opportunity is clear. The gap is regulatory—and in Africa it's a real one. Most manufacturers approach each country as a separate filing project. We design registration pathways that map dependencies across jurisdictions, eliminate redundant work, and get you to commercial launch months earlier than competitors.
We assess your product against PPB, SAHPRA, NAFDAC, and Ghana FDA requirements and identify the fastest, lowest-risk route to authorization. That might mean using an EAC joint assessment to cover three countries at once. It might mean applying for NAFDAC recognition of another country's approval. It might mean staging your launch—launching in Kenya first, then using that approval as leverage in South Africa and Nigeria.
The work includes competitive landscape analysis, market entry timeline planning, regulatory risk assessment, and detailed guidance on dossier preparation and submission sequencing. We coordinate directly with regulators when needed—responses to PPB technical queries, clarity on NAFDAC expectations, follow-up submissions to address SAHPRA concerns.
Contact us to discuss which services fit your regulatory and commercial needs.
Get in TouchFill out the form below and one of our regional market experts from Nairobi, South Africa, or Ghana will reach out to you within 24 hours.